Administration of «CORVITIN®» as an off-label agent for pharmacological correction of metabolic syndrome

Abstract

Nowadays metabolic syndrome is a noninfectious pandemic of the ХХІ century. Therefore search of effective pharmacological agents for its pharmacological correction is an urgent issue of modern medicine and pharmaceutical community. At the same time, today off-label administration of medicines (for an unapproved indication) has become widely used. This approach is based on new determined pharmacological effects of drugs unknown before. These effects were not studied during the primary development of a pharmacological agent, but they were found after its registration and appearance at the pharmaceutical market.